Caribou Biosciences Inc. (CRBU) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Caribou Biosciences Inc.

    NASDAQ: CRBU · Real-Time Price · USD
    1.85
    -0.04 (-2.12%)
    At close: Sep 04, 2025, 3:59 PM
    1.87
    1.07%
    After-hours: Sep 04, 2025, 07:19 PM EDT

    Caribou Biosciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 9.99M 34.48M 13.85M 9.6M
    Cost of Revenue
    		 3.93M 3.52M 3.64M 984K
    Gross Profit
    		 6.07M 30.95M 10.21M 8.61M
    Operating Income
    		 -166.62M -116.06M -106.4M -66.98M
    Interest Income
    		 n/a 10.7M 4.6M 148K
    Pretax Income
    		 -149.11M -101.88M -99.35M -66.6M
    Net Income
    		 -149.1M -102.07M -99.42M -66.92M
    Selling & General & Admin
    		 46.46M 38.46M 38.02M 24.32M
    Research & Development
    		 130.15M 112.08M 82.23M 52.26M
    Other Expenses
    		 -3.93M -3.52M -3.64M -984K
    Operating Expenses
    		 172.68M 147.01M 116.61M 75.59M
    Interest Expense
    		 n/a n/a n/a 8K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 176.61M 150.54M 120.25M 76.58M
    Income Tax Expense
    		 -9K 193K 70K 321K
    Shares Outstanding (Basic)
    		 90.32M 73.81M 60.8M 60.26M
    Shares Outstanding (Diluted)
    		 90.32M 73.81M 60.8M 60.26M
    EPS (Basic)
    		 -1.65 -1.38 -1.64 -1.11
    EPS (Diluted)
    		 -1.65 -1.38 -1.64 -1.11
    EBITDA
    		 -166.62M -112.53M -104.78M -66M
    EBIT
    		 -166.62M -116.06M -106.4M -66.98M
    Depreciation & Amortization
    		 3.93M 3.52M 1.62M 984K

    Add to Watchlist